D
Addex Therapeutics Ltd ADXN
$7.30 -$0.15-2.01%
Recommendation
Sell
Prev Close
$7.45
Volume
4,986
Avg Vol (90D)
21,447
Market Cap
$5.68M
Dividend & Yield
--
52-Week Range
$6.67 - $27.90
P/E (TTM)
154.89
EPS (TTM)
$0.0481
My Lists My Alerts
Rating
Reward
C
Fair
Risk
D-
Weak
Rating Factors
Growth Index
Weak
Efficiency Index
Good
Solvency Index
Excellent
Total Return Index
Very Weak
Volatility Index
Weak
Dividend Index
--
Headlines
Short Interest in Addex Therapeutics Ltd (NASDAQ:ADXN) Declines By 34.5%
1/17/2025 - Ticker Report
Addex to Present at the 2025 Swiss Equities Baader Conference
1/8/2025 - Globe Newswire
Addex Therapeutics Ltd (NASDAQ:ADXN) Short Interest Update
12/29/2024 - Ticker Report
Addex Therapeutics Ltd (NASDAQ:ADXN) Sees Large Decrease in Short Interest
12/15/2024 - Ticker Report
Are Medical Stocks Lagging ADMA Biologics (ADMA) This Year?
11/27/2024 - Zacks Investment Research
Addex Therapeutics Ltd (ADXN) Q3 2024 Earnings Call Highlights: Strategic Partnerships and ...
11/23/2024 - GuruFocus
Q3 2024 Addex Therapeutics Ltd Earnings Call Transcript
11/23/2024 - GuruFocus
Q3 2024 Addex Therapeutics Ltd Earnings Call Transcript
11/22/2024 - GuruFocus
Addex Therapeutics Ltd (ADXN) Q3 2024 Earnings Call Transcript
11/22/2024 - SeekingAlpha
Addex Therapeutics Ltd (ADXN) Q3 2024 Earnings Call Transcript
11/22/2024 - Seeking Alpha: Transcripts
Addex Reports Third Quarter 2024 Financial Results and Provides Corporate Update
11/22/2024 - Globe Newswire
Short Interest in Addex Therapeutics Ltd (NASDAQ:ADXN) Declines By 64.6%
11/14/2024 - Ticker Report
Are Medical Stocks Lagging Addex Therapeutics (ADXN) This Year?
11/11/2024 - Zacks Investment Research
Addex Provisional 2024 Third Quarter Results Showed Net Loss Compared to Second Quarter 2024
11/11/2024 - Globe Newswire
Akebia Therapeutics (AKBA) Reports Q3 Loss, Misses Revenue Estimates
11/7/2024 - Zacks Investment Research
Catalyst Pharmaceutical (CPRX) Tops Q3 Earnings and Revenue Estimates
11/6/2024 - Zacks Investment Research
Addex Therapeutics (NASDAQ:ADXN) Trading Up 9.7% - Should You Buy?
11/2/2024 - Ticker Report
Are Medical Stocks Lagging Boston Scientific (BSX) This Year?
10/25/2024 - Zacks Investment Research
Addex Therapeutics Ltd (NASDAQ:ADXN) Sees Large Decline in Short Interest
10/12/2024 - Ticker Report
Brokers Set Expectations for Addex Therapeutics Ltd's FY2024 Earnings (NASDAQ:ADXN)
10/5/2024 - Ticker Report
What Makes Addex Therapeutics (ADXN) a New Buy Stock
10/4/2024 - Zacks Investment Research
Addex Therapeutics (NASDAQ:ADXN) Rating Reiterated by HC Wainwright
10/2/2024 - Ticker Report
Addex Therapeutics Ltd (ADXN) Q2 2024 Earnings Call Transcript Highlights: Key Financials and ...
10/1/2024 - GuruFocus
Q2 2024 Addex Therapeutics Ltd Earnings Call Transcript
10/1/2024 - GuruFocus
Addex Therapeutics Ltd (ADXN) Q2 2024 Earnings Call Transcript
9/30/2024 - Seeking Alpha: Transcripts
Income Statement
Total Revenue (TTM)
$671.30K
EBITDA (TTM)
-$5.45M
EBIT (TTM)
-$5.64M
Net Income (TTM)
$5.72M
Balance Sheet
Total Assets (Q)
$14.41M
Total Debt (Q)
$51.80K
Total Liabilities (Q)
$1.31M
Book Value Per Share (Q)
$0.1332
Cash Flow
Cash from Operations (TTM)
-$6.72M
Cash from Investing (TTM)
$5.15M
Cash from Financing (TTM)
$58.20K
Net Change in Cash (TTM)
-$1.68M
Filings
Filing Date
Friday, November 22, 2024
Period Date
Monday, September 30, 2024
Next Filing
Week of Apr 14 and 18 (est)
Price History
Loading...
Beta
1.22
7-Day Total Return
-2.67%
30-Day Total Return
-6.41%
60-Day Total Return
-8.52%
90-Day Total Return
-1.08%
Year to Date Total Return
-3.19%
1-Year Total Return
-52.61%
2-Year Total Return
-63.27%
3-Year Total Return
-92.43%
5-Year Total Return
-94.59%
52-week Low
Feb 19, 2025 - $6.67
52-week High
Apr 09, 2024 - $27.90
Valuation
Market Cap
$5.68M - Nano Cap
Enterprise Value
$1.94M
Price/Sales (TTM)
1,095.59
Price/Book (Q)
55.93
Dividends and Shares
Shares Outstanding
98.30M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.addextherapeutics.com
Phone Number
41 22 884 1555
Address
Chemin des Mines, 9
Geneva, 1202
Country
Switzerland
Year Founded
2002
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The company focuses on the... more
NASDAQ 04/03/2025 3:54PM Eastern Quotes delayed
Weiss Ratings